KIPP RUSTENHOLTZ: Open Payments
NPI 1114193356 · OKEMOS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $43 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Edwards Lifesciences Corporation | 1 | $37 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Kerendia, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, ONPATTRO, JARDIANCE, TRINTELLIX, The Cologuard Plus Collection Kit, AIRSUPRA.
Industry payments across MI — which companies pay providers there.
